Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors Peer median
Net Margin for AVLN and competitors
Company Period LTM level YoY 3-year change
GYREGyre Therapeutics, Inc.LTM Mar 2026-5.4% -12.6 pp+2.1 pp
MNKDMannKind CorporationLTM Mar 2026-6.6% -16.7 pp+89.3 pp
INSMInsmed IncorporatedLTM Jun 2026-76.9% +182.9 pp-14.3 pp
VCREVicore Pharma Holding ABLTM Jun 2026-20489.5% -11011.9 pp—
AVLNAvalyn Pharma Inc. Common Stock—— ——
Peer median (excluding AVLN) -41.8%-14.7 pp+2.1 pp

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.